
Inovio Pharmaceuticals Inc (0A43)
LSE
The current 0A43 market cap is 0. The company's latest EPS is USD -0.4950 and P/E is -3.98.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 4.11M | 7.41M | 1.78M | 10.26M | 832k |
Operating Income | -114.2M | -87.53M | -301.77M | -269.47M | -143.17M |
Net Income | -119.36M | -166.41M | -303.66M | -279.82M | -135.12M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 143.95M | 539.77M | 495.94M | 348.53M | 170.95M |
Total Liabilities | 138.55M | 78.63M | 96.27M | 126.17M | 53.6M |
Total Equity | 5.41M | 461.14M | 399.67M | 222.36M | 117.35M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -97.85M | -177.98M | -215.71M | -216.22M | -124.37M |
Investing | -9.05M | -58.8M | -175.34M | 109.59M | 87.36M |
Financing | 105.4M | 465.28M | 211.5M | 81.84M | 5M |
Market Cap | 0 |
Price to Earnings Ratio | -3.98 |
Price to Sales Ratio | 656.67 |
Price to Cash Ratio | 37.6 |
Price to Book Ratio | 4.58 |
Dividend Yield | - |
Shares Outstanding | 272.99M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0 (0%) |
Company Name | Inovio Pharmaceuticals Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.inovio.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.